News

24 January 2019
Unceasingly, Copan is fostering the culture of sponsoring and supporting good causes. Passion for supporting health initiatives worldwide is in our DNA.

Copan is therefore proud to sponsor Global Initiative Against HPV and Cervical Cancer (GIAHC), which is offering a week-long webinar series in partnership with the American Medical Women’s Association (AMWA) and Indiana University (IU) in January 2019. The 1-hour webinars will be held from 12:00pm - 1:00pm EST on January 22-25 and January 28, 2019. The event is targeted for members of the public, patients, healthcare providers, and anyone else seeking further knowledge about important aspects of HPV-related disease and HPV prevention, including HPV vaccination.

Being firm and devoted, our mutual purpose is to raise and boost awareness of the Human papillomavirus (HPV) while doing our utmost to eliminate cervical cancer globally.

A well-known accelerator of sponsorship, Copan encourages GIAHC as they formulate and ameliorate  issues of worldwide health care.  At Copan, progress has got a voice. By means of our global reach, and business attitude, we are eager to produce valuable public and business awareness in order to enhance the efficacy of such relevant initiatives.

 Us vs. HPV ‘s mission is to create a collaborative community dedicated to educating clinicians and the public about the HPV virus, its disease consequences, prevention and management. The goal of “All-of-Us” is to do all in its power to assist and boost certain cancer initiative. Commitment and perseverance fuel success and progress.

Copan takes its role seriously when making an affirmative effort to sustain and improve the all-encompassing health and wellness of patients. / Copan is another all- encompassing health adherent.

 

againstHPV1.pngagainstHPV.jpeg

04 June 2018

Brescia, Italy – June 1st, 2018 COPAN Italia S.p.A. and its U.S. subsidiary, COPAN Diagnostics Inc. announced today that they have filed a lawsuit against Puritan Medical Products Co., LLC and Puritan Diagnostics LLC, in the United States District Court for the District of Maine for infringement of U.S. Patent No. 8,114,027, U.S. Patent No. 8,317,728, U.S. Patent No. 8,979,784, U.S. Patent No. 9,011,358, and U.S. Patent No. 9,173,779. 

May 2018

Daniele Triva Memorial Post-Doctoral Fellowship in Diagnostic Clinical Microbiology
Description:

This one-year post-doctoral fellowship supports the successful candidate for an intense, applied and project-oriented fellowship experience in diagnostic clinical microbiology under the supervision of two McMaster University faculty, in the setting of one of Canada’s busiest and most innovative clinical microbiology laboratories.

Daniele Triva was a brilliant and visionary leader of Copan Italia, whose innovation in pre-analytic methods, liquid microbiology, and laboratory automation forever changed how microbiology laboratories diagnose infectious diseases. For over 20 years, McMaster University, the Hamilton Regional Laboratory Medicine Program (HRLMP) and Copan Italia have collaborated in diagnostic research and implementation of automation in the clinical laboratory. Today, HRLMP is renowned for its leadership and expertise in virology, molecular diagnostics and laboratory automation, providing clinical microbiology services to over a dozen Ontario hospitals. This unique fellowship continues this long-standing collaboration.

Dicember 05, 2017 - Murrieta CA

Recent multicenter study by Dr. Carey-Ann D. Burnham et al adds another application to the growing number of uses and endorsements for COPAN’s widely popular ESwab®. ESwab® comprises of 1ml of liquid Amies and a flocked swab that completely elutes the sample into the preservation medium. Its versatility and universal appeal simplifies sample collection by minimizing the plethora of specimen collection swabs that need to be stocked by medical centers and clinics in favor of a single multipurpose bacteriology swab.

Copan Italia - 9 November, 2017 - Brescia, Italy

Copan Italia SpA and Shinji Matsuura proudly announce the formation of a joint venture for the strategic promotion and distribution of Copan’s Liquid Based Microbiology™ (LBM®) range in Japan.

Murrieta, CA – September 28, 2017 

Apparently, many Americans spend the holidays doing more than hanging up stockings and trimming the tree. September happens to wear the noteworthy title of “most popular birth month in the United States”. Count back nine months and … you get the point.

Murrieta, CA – September 14, 2017 

It isn’t every day that a company hits four milestones with the placement of one system. But that is exactly what happened last month at the University Health Network/Sinai Health System’s Department of Microbiology in Toronto, Ontario when COPAN installed WASPLab®, a fully automated specimen processor and work-up system for microbiology, which comprises robotic culture and incubation of specimens, digital imaging and artificial intelligence to assist interpretation and reporting of patient results.

Murrieta, CA – July 24, 2017

After a successful launch at the American Society for Microbiology (ASM) Microbe 2017, COPAN is showcasing PhenoMATRIX™ to a wider audience at the American Association for Clinical Chemistry (AACC) annual meeting at the San Diego Convention Center from August 1 through August 3.

Page 1 of 2